1,005
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Relationship between intestinal microbiota, diet and biological systems: an integrated view

, , , , , , , , & show all

References

  • Aghajanpour, M., M. R. Nazer, Z. Obeidavi, M. Akbari, P. Ezati, and N. M. Kor. 2017. Functional foods and their role in cancer prevention and health promotion: A comprehensive review. American Journal of Cancer Research 7 (4):740–69.
  • Aizawa, E., H. Tsuji, T. Asahara, T. Takahashi, T. Teraishi, S. Yoshida, M. Ota, N. Koga, K. Hattori, and H. Kunug. 2016. Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder. Journal of Affective Disorders 202:254–7. doi: 10.1016/j.jad.2016.05.038.
  • Akkasheh, G., Z. Kashani-Poor, M. Tajabadi-Ebrahimi, P. Jafari, H. Akbari, M. Taghizadeh, M. R. Memarzadeh, Z. Asemi, and A. Esmaillzadeh. 2016. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition (Burbank, Los Angeles County, Calif.) 32 (3):315–20. doi: 10.1016/j.nut.2015.09.003.
  • Ali, M., and D. R. Duerksen. 2008. Ulcerative colitis and Sweet's syndrome: A case report and review of the literature. Canadian Journal of Gastroenterology = Journal Canadien de Gastroenterologie 22 (3):296–8. doi: 10.1155/2008/960585.
  • Ali, A. M., M. N. Ayman, and M. A. Mahmoud. 2016. Helicobacter pylori infection and its potential role in childhood eczema. Immunological Techniques & Infectious Diseases 5:1. doi: 10.4172/2329-9541.1000136.
  • Amit‐Romach, E., Z. Uni, and R. Reifen. 2010. Multistep mechanism of probiotic bacterium, the effect on innate immune system. Molecular Nutrition & Food Research 54 (2):277–84. doi: 10.1002/mnfr.200800591.
  • Andia, D. C., P. S. Cerri, and L. C. Spolidorio. 2006. Tecido ósseo: Aspectos morfológicos e histofisiológicos. Revista de Odontologia da UNESP 35:191–8.
  • Argilés, J. M., S. Busquets, and F. J. López-Soriano. 2003. Cytokines in the pathogenesis of cancer cachexia. Current Opinion in Clinical Nutrition and Metabolic Care 6 (4):401–6. doi: 10.1097/01.mco.0000078983.18774.cc.
  • Arora, T., S. Singh, and R. K. Sharma. 2013. Probiotics: Interaction with gut microbiome and antiobesity potential. Nutrition (Burbank, Los Angeles County, Calif.) 29 (4):591–6. doi: 10.1016/j.nut.2012.07.017.
  • Arumugam, M., J. Raes, E. Pelletier, D. Le Paslier, T. Yamada, D. R. Mende, G. R. Fernandes, J. Tap, T. Bruls, J. M. Batto, et al. 2011. Enterotypes of the human gut microbiome. Nature 473 (7346):174–80., doi: 10.1038/nature09944.
  • Azad, M. D., A. Kalam, M. Sarker, T. Li, and J. Yin. 2018. Probiotic species in the modulation of gut microbiota: An overview. BioMed Research International 2018:9478630–8. doi: 10.1155/2018/9478630.
  • Bao, Y., K. F. Al, R. M. Chanyi, S. Whiteside, M. Dewar, H. Razvi, G. Reid, and J. P. Burton. 2017. Questions and challenges associated with studying the microbiome of the urinary tract. Annals of Translational Medicine 5 (2):33. doi: 10.21037/atm.2016.12.14.
  • Barrett, E., R. P. Ross, P. W. O'Toole, G. F. Fitzgerald, and C. Stanton. 2012. γ-Aminobutyric acid production by culturable bacteria from the human intestine. Journal of Applied Microbiology 113 (2):411–7. doi: 10.1111/j.1365-2672.2012.05344.x.
  • Bassis, C. M., J. R. Erb-Downward, R. P. Dickson, C. M. Freeman, T. M. Schmidt, V. B. Young, J. M. Beck, J. L. Curtis, and G. B. Huffnagle. 2015. Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio 6 (2):e00037. doi: 10.1128/mBio.00037-15.
  • Belizario, J. E., and M. Napolitano. 2015. Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Frontiers in Microbiology 6:1050–16. doi: 10.3389/fmicb.2015.01050.
  • Belkaid, Y., and T. W. Hand. 2014. Role of the microbiota in immunity and inflammation. Cell 157 (1):121–41. doi: 10.1016/j.cell.2014.03.011.
  • Beyitler, I., and S. Kavukcu. 2017. Probiotics for prophylaxis and treatment of urinary tract infections in children. Iranian Journal of Pediatrics 27:e7695. doi: 10.5812/ijp.7695.
  • Bindels, L. B., and N. M. Delzenne. 2013. Muscle wasting: The gut microbiota as a new therapeutic target? The International Journal of Biochemistry & Cell Biology 45 (10):2186–90. doi: 10.1016/j.biocel.2013.06.021.
  • Britton, R. A., R. Irwin, D. Quach, L. Schaefer, J. Zhang, T. Lee, N. Parameswaran, and L. R. McCabe. 2014. Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. Journal of Cellular Physiology 229 (11):1822–30. doi: 10.1002/jcp.24636.
  • Brown, K., D. DeCoffe, E. Molcan, and D. L. Gibson. 2012. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 4 (8):1095–119. doi: 10.3390/nu4081095.
  • Brown, J. M., and S. L. Hazen. 2015. The gut microbial endocrine organ: Bacterially derived signals driving cardiometabolic diseases. Annual Review of Medicine 66:343–59. doi: 10.1146/annurev-med-060513-093205.
  • Brubaker, L., and A. J. Wolfe. 2016. The urinary microbiota: A paradigm shift for bladder disorders? Current Opinion in Obstetrics & Gynecology 28 (5):407–12. doi: 10.1097/GCO.0000000000000298.
  • Brubaker, L., and A. J. Wolfe. 2017. The female urinary microbiota, urinary health and common urinary disorders. Annals of Translational Medicine 5 (2):34 doi: 10.21037/atm.2016.11.62.
  • Boudry, G., M. K. Hamilton, M. Chichlowski, S. Wickramasinghe, D. Barile, K. M. Kalanetra, D. A. Mills, and H. E. Raybould. 2017. Bovine milk oligosaccharides decrease gut permeability and improve inflammation and microbial dysbiosis in diet-induced obese mice. Journal of Dairy Science 100 (4):2471–81. doi: 10.3168/jds.2016-11890.
  • Budhram, A., S. Parvathy, M. Kremenchutzky, and M. Silverman. 2017. Breaking down the gut microbiome composition in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England) 23 (5):628–36. doi: 10.1177/1352458516682105.
  • Buffington, S. A., G. V. Di Prisco, T. A. Auchtung, N. J. Ajami, J. F. Petrosino, and M. Costa-Mattioli. 2016. Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell 165 (7):1762–75. doi: 10.1016/j.cell.2016.06.001.
  • Byndloss, M. X., E. E. Olsan, F. Rivera-Chávez, C. R. Tiffany, S. A. Cevallos, K. L. Lokken, T. P. Torres, A. J. Byndloss, F. Faber, Y. Gao, et al. 2017. Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion. Science (New York, N.Y.) 357 (6351):570–5., doi:10.1126/science.aam9949.
  • Byrd, A. L., Y. Belkaid, and J. A. Segre. 2018. The human skin microbiome. Nature Reviews. Microbiology 16 (3):143–55. doi: 10.1038/nrmicro.2017.157.
  • Calças, N., L. Mendonça, L. Perez, R. Ferreira, C. Elisei, and, A. Castro. 2017. Diet as a therapy for gutdysbacteriosos. JSM Biochemistry & Molecular Biology 4 (1):1021.
  • Cani, P. D., A. Everard, and T. Duparc. 2013. Gut microbiota, enteroendocrine functions and metabolism. Current Opinion in Pharmacology 13 (6):935–40. doi: 10.1016/j.coph.2013.09.008.
  • Cantarel, B. L., E. Waubant, C. Chehoud, J. Kuczynski, T. Z. DeSantis, J. Warrington, A. Venkatesan, C. M. Fraser, and E. M. Mowry. 2015. Gut microbiota in multiple sclerosis: Possible influence of immunomodulators. Journal of Investigative Medicine: The Official Publication of the American Federation for Clinical Research 63 (5):729–34. doi: 10.1097/JIM.0000000000000192.
  • Carabotti, M., A. Scirocco, M. A. Maselli, and C. Severi. 2015. The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems. Annals of Gastroenterology 28 (2):203–9.
  • Caricilli, A. M., P. K. Picardi, L. L. de Abreu, M. Ueno, P. O. Prada, E. R. Ropelle, S. M. Hirabara, Â. Castoldi, P. Vieira, N. O. S. Camara, et al. 2011. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biology 9 (12):e1001212. doi: 10.1371/journal.pbio.1001212.
  • Carlet, J. 2012. The gut is the epicentre of antibiotic resistance. Antimicrob Resist Infect Control 1 (1):39. doi: 10.1186/2047-2994-1-39.
  • Cekanaviciute, E., J. W. Debelius, S. Singh, T. Runia, C. Nelson, B. Yoo, R. Kanner, E. Crabtree-Hartman, S. Mazmanian, R. Knight, et al. 2016., Gut dysbiosis is a feature of MS and it is characterized by bacteria able to regulate lymphocyte differentiation in vitro. Accessed April 30, 2019. http://onlinelibrary.ectrims-congress.eu/ectrims/2016/32nd/147026/sergio.e.baranzini.gut.dysbiosis.is.a.feature.of.ms.and.it.is.characterized.by.html?f=m3.
  • Chen, Y., N. A. Patel, A. Crombie, J. H. Scrivens, and J. C. Murrell. 2011. Bacterial flavin-containing monooxygenase is trimethylamine monooxygenase. Proceedings of the National Academy of Sciences of the United States of America 108 (43):17791–6. doi: 10.1073/pnas.1112928108.
  • Chen, J., K. Wright, J. M. Davis, P. Jeraldo, E. V. Marietta, J. Murray, H. Nelson, E. L. Matteson, and V. Taneja. 2016. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Medicine 8 (1):43. doi: 10.1186/s13073-016-0299-7.
  • Chen, Y. C., J. Greenbaum, H. Shen, and H. W. Deng. 2017. Association between gut microbiota and bone health: Potential mechanisms and Prospective. J Clin Endocrinol Metab 102 (10):3635–46. doi: 10.1210/jc.2017-00513.
  • Chiang, S. S., and T. M. Pan. 2011. Antiosteoporotic effects of lactobacillus fermented soy skim milk on bone mineral density and the microstructure of femoral bone in ovariectomized mice. Journal of Agricultural and Food Chemistry 59 (14):7734–42. http://. doi: 10.1021/jf2013716.
  • Cho, I., and M. J. Blaser. 2012. The human microbiome: At the interface of health and disease. Nature Reviews. Genetics 13 (4):260–70. htpps://doi: 10.1038/nrg3182.
  • Clarke, T. B. 2014. Early innate immunity to bacterial infection in the lung is regulated systemically by the commensal microbiota via Nod-like receptor ligands. Infection and Immunity 82 (11):4596–606. http://. doi: 10.1128/IAI.02212-14.
  • Codoñer, F. M., A. Ramírez-Bosca, E. Climent, M. Carrión-Gutierrez, M. Guerrero, J. M. Pérez-Orquín, J. Horga de la Parte, S. Genovés, D. Ramón, V. Navarro-López, et al. 2018. Gut microbial composition in patients with psoriasis. Scientific Reports 8 (1):3812 http://. doi: 10.1038/s41598-018-22125-y.
  • Collins, F. L., R. Irwin, H. Bierhalter, J. Schepper, R. A. Britton, N. Parameswaran, and L. R. McCabe. 2016. Lactobacillus reuteri 6475 increases bone density in intact females only under an inflammatory setting. Plos One 11 (4):e0153180. doi: 10.1371/journal.pone.0153180.
  • Collins, K. H., H. A. Paul, D. A. Hart, R. A. Reimer, I. C. Smith, J. L. Rios, R. A. Seerattan, and W. Herzog. 2016. A high-fat high-sucrose diet rapidly alters muscle integrity, inflammation and gut microbiota in male rats. Scientific Reports 6:37278. doi: 10.1038/srep37278.
  • Conlon, A. M., and R. A. Bird. 2014. The impact of diet and lifestyle on gut microbiota and human health. Nutrients 7 (1):17–44. doi: 10.3390/nu7010017.
  • Cortes-Penfield, N. W., B. W. Trautner, and R. L. P. Jump. 2017. Urinary tract infection and asymptomatic bacteriuria in older adults. Infectious Disease Clinics of North America 31 (4):673–88. doi: 10.1016/j.idc.2017.07.002.
  • Cruvinel, W. M., J. D. Mesquita, J. A. P. Araújo, T. T. T. Catelan, A. W. S. Souza, N. P. Silva, and L. E. C. Andrade. 2010. Sistema imunitário: Parte I. Fundamentos da imunidade inata com ênfase nos mecanismos moleculares e celulares da resposta inflamatória. Revista Brasileira de Reumatologia 50 (4):434–61. doi:10.1590/S0482-50042010000400008.
  • Cruz-Jentoft, A. J., J. P. Baeyens, J. M. Bauer, Y. Boirie, T. Cederholm, F. Landi, F. C. Martin, J. P. Michel, Y. Rolland, S. M. Schneider, et al. 2010. Sarcopenia: European consensus on definition and diagnosis Report of the European Working Group on Sarcopenia in Older People. Age and Ageing 39 (4):412–23. doi: 10.1093/ageing/afq034.
  • Cryan, J. F., and K. Kaupmann. 2005. Don't worry 'B' happy!: A role for GABA(B) receptors in anxiety and depression. Trends in Pharmacological Sciences 26 (1):36–43. doi: 10.1016/j.tips.2004.11.004.
  • DeGruttola, A. K., D. Low, A. Mizoguchi, and E. Mizoguchi. 2016. Current understanding of dysbiosis in disease in human and animal models. Inflammatory Bowel Diseases 22 (5):1137–50. doi: 10.1097/MIB.0000000000000750.
  • Delli Pizzi, S., C. Padulo, A. Brancucci, G. Bubbico, R. A. Edden, A. Ferretti, R. Franciotti, V. Manippa, D. Marzoli, M. Onofrj, et al. 2016. GABA content within the ventromedial prefrontal cortex is related to trait anxiety. Social Cognitive and Affective Neuroscience 11 (5):758–66., doi: 10.1093/scan/nsv155.
  • Delzenne, N. M., and P. D. Cani. 2011. Interaction between obesity and the gut microbiota: Relevance in nutrition. Annual Review of Nutrition 31:15–31. doi: 10.1146/annurev-nutr-072610-145146.
  • Desbonnet, L., L. Garrett, G. Clarke, B. Kiely, J. F. Cryan, and T. G. Dinan. 2010. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170 (4):1179–88. doi: 10.1016/j.neuroscience.2010.08.005.
  • De Vos, W. M., and E. A. De Vos. 2012. Role of the intestinal microbiome in health and disease: From correlation to causation. Nutrition Reviews 70:S45–S56. doi: 10.1111/j.1753-4887.2012.00505.x.
  • Dickson, R. P., J. R. Erb-Downward, C. M. Freeman, L. McCloskey, J. M. Beck, G. B. Huffnagle, and J. L. Curtis. 2015. Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Annals of the American Thoracic Society 12 (6):821–30. doi: 10.1513/AnnalsATS.201501-029OC.
  • Di Giacinto, C., M. Marinaro, M. Sanchez, W. Strober, and M. Boirivant. 2005. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells . Journal of Immunology (Baltimore, Md. : 1950) 174 (6):3237–46. doi: 10.4049/jimmunol.174.6.3237.
  • Dockray, G. J. 2014. Gastrointestinal hormones and the dialogue between gut and brain. The Journal of Physiology 592 (14):2927–41. doi: 10.1113/jphysiol.2014.270850.
  • Dodson, S., V. E. Baracos, A. Jatoi, W. J. Evans, D. Cella, J. T. Dalton, and M. S. Steiner. 2011. Muscle wasting in cancer cachexia: Clinical implications, diagnosis, and emerging treatment strategies. Annual Review of Medicine 62:265–79. doi: 10.1146/annurev-med-061509-131248.
  • Druart, C., M. Alligier, N. Salazar, A. M. Neyrinck, and N. M. Delzenne. 2014. Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties. Advances in Nutrition (Bethesda, Md.) 5 (5):624S–33s. doi: 10.3945/an.114.005835.
  • Egshatyan, L., D. Kashtanova, A. Popenko, O. Tkacheva, A. Tyakht, D. Alexeev, N. Karamnova, E. Kostryukova, V. Babenko, M. Vakhitova, et al. 2016. Gut microbiota and diet in patients with different glucose tolerance. Endocrine Connections 5 (1):1–9. doi: 10.1530/EC-15-0094.
  • Einarsson, G., D. Comer, L. McIlreavey, J. Parkhill, M. Ennis, M. Tunney, and J. Elborn. 2016. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers. Thorax 71 (9):795–803. doi: 10.1136/thoraxjnl-2015-207235.
  • Eppinga, H., S. R. Konstantinov, M. P. Peppelenbosch, and H. B. Thio. 2014. The microbiome and psoriatic arthritis. Current Rheumatology Reports 16 (3):407 doi: 10.1007/s11926-013-0407-2.
  • Erb-Downward, J. R., D. L. Thompson, M. K. Han, C. M. Freeman, L. McCloskey, L. A. Schmidt, V. B. Young, G. B. Toews, J. L. Curtis, B. Sundaram, et al. 2011. Analysis of the lung microbiome in the “healthy” smoker and in COPD. Plos One 6 (2):e16384 doi: 10.1371/journal.pone.0016384.
  • Eslamparast, T., F. Zamani, A. Hekmatdoost, M. Sharafkhah, S. Eghtesad, R. Malekzadeh, and H. Poustchi. 2014. Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: A randomised, double-blind, placebo-controlled pilot study. British Journal of Nutrition 112 (3):438–45. . PMid:24848793. doi: 10.1017/S0007114514000919.
  • Fang, S., X. Xiong, Y. Su, L. Huang, and C. Chen. 2017. 16S rRNA gene-based association study identified microbial taxa associated with pork intramuscular fat content in feces and cecum lumen. BMC Microbiology 17 (1):162. doi: 10.1186/s12866-017-1055-x.
  • Fasano, A., N. P. Visanji, L. W. Liu, A. E. Lang, and R. F. Pfeiffer. 2015. Gastrointestinal dysfunction in Parkinson's disease. The Lancet Neurology 14 (6):625–39. doi: 10.1016/S1474-4422(15)00007-1.
  • Fastrès, A., F. Felice, E. Roels, C. Moermans, J.-L. Corhay, F. Bureau, R. Louis, C. Clercx, and J. Guiot. 2017. The lung microbiome in idiopathic pulmonary fibrosis: A promising approach for targeted therapies. International Journal of Molecular Sciences 18 (12):2735. doi: 10.3390/ijms18122735.
  • Fearnley, J. M., and A. J. Lees. 1991. Ageing and Parkinson's disease: Substantia nigra regional selectivity. Brain 114 (5):2283–301. doi: 10.1093/brain/114.5.2283.
  • Fearon, K. C., D. J. Glass, and D. C. Guttridge. 2012. Cancer cachexia: Mediators, signaling, and metabolic pathways. Cell Metab 16 (2):153–66. doi: 10.1016/j.cmet.2012.06.011.
  • Finegold, S. M., S. E. Dowd, V. Gontcharova, C. Liu, K. E. Henley, R. D. Wolcott, E. Youn, P. H. Summanen, D. Granpeesheh, D. Dixon, et al. 2010. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16 (4):444–53., doi: 10.1016/j.anaerobe.2010.06.008.
  • Foster, J. A., and K.-A. M. Neufeld. 2013. Gut-brain axis: How the microbiome influences anxiety and depression. Trends in Neurosciences 36 (5):305–12. doi: 10.1016/j.tins.2013.01.005.
  • Friaza, V., C. de la Horra, M. J. Rodríguez-Domínguez, J. Martín-Juan, R. Cantón, E. J. Calderón, and R. del Campo. 2010. Metagenomic analysis of bronchoalveolar lavage samples from patients with idiopathic interstitial pneumonia and its antagonic relation with Pneumocystis jirovecii colonization. Journal of Microbiological Methods 82 (1):98–101. doi: 10.1016/j.mimet.2010.03.026.
  • Fröhlich, E. E., A. Farzi, R. Mayerhofer, F. Reichmann, A. Jačan, B. Wagner, E. Zinser, N. Bordag, C. Magnes, E. Fröhlich, et al. 2016. Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication. Brain, Behavior, and Immunity 56:140–55. doi: 10.1016/j.bbi.2016.02.020.
  • Fu, J., M. J. Bonder, M. C. Cenit, E. F. Tigchelaar, A. Maatman, J. A. Dekens, E. Brandsma, J. Marczynska, F. Imhann, R. K. Weersma, et al. 2015. The gut microbiome contributes to a substantial proportion of the variation in blood lipids. Circulation Research 117 (9):817–24. doi: 10.1161/CIRCRESAHA.115.306807.
  • Fu, Q., M. Zhao, D. Wang, H. Hu, C. Guo, W. Chen, Q. Li, L. Zheng, and B. Chen. 2016. Coronary plaque characterization assessed by optical coherence tomography and plasma trimethylamine-N-oxide levels in patients with coronary artery disease. The American Journal of Cardiology 118 (9):1311–5. doi: 10.1016/j.amjcard.2016.07.071.
  • Fuller, R. 1991. Probiotics in human medicine. Gut 32 (4):439–42. doi: 10.1136/gut.32.4.439.
  • Gao, Z., J. Yin, J. Zhang, R. E. Ward, R. J. Martin, M. Lefevre, W. T. Cefalu, and J. Ye. 2009. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58 (7):1509–17. doi: 10.2337/db08-1637.
  • García-Niño, W. R., E. Tapia, C. Zazueta, Z. L. Zatarain-Barrón, R. Hernández-Pando, C. C. Vega-García, and J. Pedraza-Chaverrí. 2013. Curcumin pretreatment prevents potassium dichromate-induced hepatotoxicity, oxidative stress, decreased respiratory complex I activity, and membrane permeability transition pore opening. Evidence-Based Complementary and Alternative Medicine: eCAM 2013:424692. doi: 10.1155/2013/424692.
  • Genton, L., P. D. Cani, and J. Schrenzel. 2015. Alterations of gut barrier and gut microbiota in food restriction, food deprivation and protein-energy wasting. Clinical Nutrition (Edinburgh, Scotland) 34 (3):341–9. doi: 10.1016/j.clnu.2014.10.003.
  • Ghanem, K. Z., I. H. Badawy, and A. M. Abdel Salam. 2004. Influence of yoghurt and probiotic yoghurt on the absorption of calcium, magnesium, iron and bone mineralization in rats. Milchwissenschaft 59:472–5.
  • Giloteaux, L., J. K. Goodrich, W. A. Walters, S. M. Levine, R. E. Ley, and M. R. Hanson. 2016. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome 4 (1):30. doi: 10.1186/s40168-016-0171-4.
  • Glover, L. E., and S. P. Colgan. 2017. Epithelial barrier regulation by hypoxia-inducible factor. Annals of the American Thoracic Society 14 (Supplement_3):S233–S236. doi: 10.1513/AnnalsATS.201608-610MG.
  • Golombos, D. M., A. Ayangbesan, P. O'Malley, P. Lewicki, L. Barlow, C. E. Barbieri, C. Chan, C. DuLong, G. Abu-Ali, C. Huttenhower, et al. 2018. The role of gut microbiome in the pathogenesis of prostate cancer: A prospective, pilot study. Urology 111:122–8. doi: 10.1016/j.urology.2017.08.039.
  • Grosicki, G. J., R. A. Fielding, and M. S. Lustgarten. 2018. Gut microbiota contribute to age-related changes in skeletal muscle size, composition, and function: Biological basis for a gut-muscle Axis. Calcif Tissue Int 102 (4):433–42. doi: 10.1007/s00223-017-0345-5.
  • Guarner, F. 2007. Hygiene, microbial diversity and immune regulation. Current Opinion in Gastroenterology 23 (6):667–72. doi: 10.1097/MOG.0b013e3282eeb43b.
  • Guida, F., F. Turco, M. Iannotta, D. De Gregorio, I. Palumbo, G. Sarnelli, A. Furiano, F. Napolitano, S. Boccella, L. Luongo, et al. 2018. Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice. Brain, Behavior, and Immunity 67:230–45. doi: 10.1016/j.bbi.2017.09.001.
  • Guinane, C. M., and P. D. Cotter. 2013. Role of the gut microbiota in health and chronic gastrointestinal disease: Understanding a hidden metabolic organ. Therapeutic Advances in Gastroenterology 6 (4):295–308. doi: 10.1177/1756283X13482996.
  • Gul'neva, M., and S. Noskov. 2011. Colonic microbial biocenosis in rheumatoid arthritis. Klin Medicine 89:45–8.
  • Guo, Y., Y. Qi, X. Yang, L. Zhao, S. Wen, Y. Liu, and L. Tang. 2016. Association between polycystic ovary syndrome and gut microbiota. Plos One 11 (4):e0153196. doi: 10.1371/journal.pone.0153196.
  • Harach, T., N. Marungruang, N. Dutilleul, V. Cheatham, K. Mc Coy, J. Neher, M. Jucker, F. Fåk, and T. Bolmont. 2015. Reduction of Alzheimer's disease beta-amyloid pathology in the absence of gut microbiota 2.
  • Hasegawa, S., S. Goto, H. Tsuji, T. Okuno, T. Asahara, K. Nomoto, A. Shibata, Y. Fujisawa, T. Minato, A. Okamoto, et al. 2015. Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's Disease. Plos One 10 (11):e0142164. doi: 10.1371/journal.pone.0142164.
  • Hashimoto, T., T. Perlot, A. Rehman, J. Trichereau, H. Ishiguro, M. Paolino, V. Sigl, T. Hanada, R. Hanada, S. Lipinski, et al. 2012. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487 (7408):477–81. doi: 10.1038/nature11228.
  • Hatakka, K., J. Martio, M. Korpela, M. Herranen, T. Poussa, T. Laasanen, M. Saxelin, H. Vapaatalo, E. Moilanen, and R. Korpela. 2003. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis-a pilot study. Scandinavian Journal of Rheumatology 32 (4):211–5. doi: 10.1080/03009740310003695.
  • Hauptmann, M., and U. E. Schaible. 2016. Linking microbiota and respiratory disease. FEBS Letters 590 (21):3721–38. doi: 10.1002/1873-3468.12421.
  • He, M., and B. Shi. 2017. Gut microbiotta as a potential target of metabolic syndrome: The role of probiotics and prebiotics. Cell & Bioscience 7 (54) doi: 10.118/s13578-017-0183-1.
  • Hedemann, M. S., P. K. Theil, and K. E. B. Knudsen. 2009. The thickness of the intestinal mucous layer in the colon of rats fed various sources of non-digestible carbohydrates is positively correlated with the pool of SCFA but negatively correlated with the proportion of butyric acid in digesta. British Journal of Nutrition 102 (1):117–25. doi: 10.1017/S0007114508143549.
  • Hernández, J. L., R. López-Mejías, R. Blanco, T. Pina, S. Ruiz, I. Sierra, B. Ubilla, V. Mijares, M. A. González-López, S. Armesto, et al. 2016. Association of trabecular bone score with inflammation and adiposity in patients with psoriasis: Effect of adalimumab therapy. Journal of Osteoporosis 2016:1–6. doi: 10.1155/2016/5747852.
  • Hevia, A., C. Milani, P. López, A. Cuervo, S. Arboleya, S. Duranti, F. Turroni, S. González, A. Suárez, M. Gueimonde, et al. 2014. Intestinal dysbiosis associated with systemic lupus erythematosus. MBio 5 (5):e01548. doi: 10.1128/mBio.01548-14.
  • Holmberg, F. E., J. Pedersen, P. Jørgensen, C. Soendergaard, K. B. Jensen, and O. H. Nielsen. 2018. Intestinal barrier integrity and inflammatory bowel disease: Stem cell-based approaches to regenerate the barrier . Journal of Tissue Engineering and Regenerative Medicine 12 (4):923–35. doi: 10.1002/term.2506.
  • Hong, Y. H., Y. Nishimura, D. Hishikawa, H. Tsuzuki, H. Miyahara, C. Gotoh, K. C. Choi, D. D. Feng, C. Chen, H. G. Lee, et al. 2005. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology 146 (12):5092–9., doi: 10.1210/en.2005-0545.
  • Hooper, L. V., and A. J. Macpherson. 2010. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nature Reviews. Immunology 10 (3):159–69. doi: 10.1038/nri2710.
  • Hooper, L. V., D. R. Littman, and A. J. Macpherson. 2012. Interactions between the microbiota and the immune system. Science (New York, N.Y.) 336 (6086):1268–73. doi: 10.1126/science.1223490.
  • Hou, K., C. Lin, C. Chen, B. Wu, D. Zhu, W. Zhong, X. Wang, X. Xie, and Q. Chen. 2017. Association of probiotics and bone mineral density in Chinese patients with type 2 diabetes. Biomedical Research 28:129–33.
  • Horwitz, D., T. McCue, A. C. Mapes, N. J. Ajami, J. F. Petrosino, R. F. Ramig, and B. W. Trautner. 2015. Decreased microbiota diversity associated with urinary tract infection in a trial of bacterial interference. The Journal of Infection 71 (3):358–67. doi: 10.1016/j.jinf.2015.05.014.
  • Hsiao, E. Y., S. W. McBride, S. Hsien, G. Sharon, E. R. Hyde, T. McCue, J. A. Codelli, J. Chow, S. E. Reisman, J. F. Petrosino, et al. 2013. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155 (7):1451–63., doi: 10.1016/j.cell.2013.11.024.
  • Huttenhower, C., D. Gevers, R. Knight, S. Abubucker, J. H. Badger, A. T. Chinwalla, H. H. Creasy, A. M. Earl, M. G. FitzGerald, R. S. Fulton, et al. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486:207–14. doi: 10.1038/nature11234.
  • Jagadeesh, T. A., P. Y. Prakash, N. Karthik Rao, and V. Ramya. 2017. Culture characterization of the skin microbiome in Type 2 diabetes mellitus: A focus on the role of innate immunity. Diabetes Research and Clinical Practice 134:1–7. doi: 10.1016/j.diabres.2017.09.007.
  • Jangi, S., R. Gandhi, L. M. Cox, N. Li, F. von Glehn, R. Yan, B. Patel, M. A. Mazzola, S. Liu, B. L. Glanz, et al. 2016. Alterations of the human gut microbiome in multiple sclerosis. Nature Communications 7:12015. htpps://doi: 10.1038/ncomms12015.
  • Jenks, K., S. Stebbings, J. Burton, M. Schultz, P. Herbison, and J. Highton. 2010. Probiotic therapy for the treatment of Spondyloarthritis: A randomized controlled trial. J Rheumatol 37 (10):2118–25. doi: 10.3899/jrheum.100193.
  • Jeon, S. G., H. Kayama, Y. Ueda, T. Takahashi, T. Asahara, H. Tsuji, N. M. Tsuji, H. Kiyono, J. S. Ma, T. Kusu, et al. 2012. Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathogens 8 (5):e1002714 doi: 10.1371/journal.ppat.1002714.
  • Jiang, S., S. Xie, D. Lv, P. Wang, H. He, T. Zhang, Y. Zhou, Q. Lin, H. Zhou, J. Jiang, et al. 2017. Alteration of the gut microbiota in Chinese population with chronic kidney disease. Scientific Reports 7 (1):2870. doi: 10.1038/s41598-017-02989-2.
  • Jones, R. M., J. G. Mulle, and R. Pacifici. 2018. Osteomicrobiology: The influence of gut microbiota on bone in health and disease. Bone 115:59–67. doi: 10.1016/j.bone.2017.04.009.
  • Kabouridis, P. S., R. Lasrado, S. McCallum, S. H. Chng, H. J. Snippert, H. Clevers, S. Pettersson, and V. Pachnis. 2015. Microbiota controls the homeostasis of glial cells in the gut lamina propria. Neuron 85 (2):289–95. doi: 10.1016/j.neuron.2014.12.037.
  • Kaji, I., S-i Karaki, R. Tanaka, and A. Kuwahara. 2011. Density distribution of free fatty acid receptor 2 (FFA2)-expressing and GLP-1-producing enteroendocrine L cells in human and rat lower intestine, and increased cell numbers after ingestion of fructo-oligosaccharide. Journal of Molecular Histology 42 (1):27–38. doi: 10.1007/s10735-010-9304-4.
  • Karlsson, F. H., F. Fåk, I. Nookaew, V. Tremaroli, B. Fagerberg, D. Petranovic, F. Bäckhed, and J. Nielsen. 2012. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nature Communications 3:1245. doi: 10.1038/ncomms2266.
  • Karlsson, F. H., V. Tremaroli, I. Nookaew, G. Bergström, C. J. Behre, B. Fagerberg, J. Nielsen, and F. Bäckhed. 2013. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498 (7452):99–103. doi: 10.1038/nature12198.
  • Karstens, L., M. Asquith, S. Davin, P. Stauffer, D. Fair, W. T. Gregory, J. T. Rosenbaum, S. K. McWeeney, and R. Nardos. 2016. Does the urinary microbiome play a role in urgency urinary incontinence and its severity? Frontiers in Cellular and Infection Microbiology 6:78. doi: 10.3389/fcimb.2016.00078.
  • Kelly, C. J., L. Zheng, E. L. Campbell, B. Saeedi, C. C. Scholz, A. J. Bayless, K. E. Wilson, L. E. Glover, D. J. Kominsky, A. Magnuson, et al. 2015. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 17 (5):662–71.,doi: 10.1016/j.chom.2015.03.005. 2015.
  • Kerr, C. A., D. M. Grice, C. D. Tran, D. C. Bauer, D. Li, P. Hendry, and G. N. Hannan. 2015. Early life events influence whole-of-life metabolic health via gut microflora and gut permeability. Critical Reviews in Microbiology 41 (3):326–40. doi: 10.3109/1040841X.2013.837863.
  • Keshavarzian, A., S. J. Green, P. A. Engen, R. M. Voigt, A. Naqib, C. B. Forsyth, E. Mutlu, and K. M. Shannon. 2015. Colonic bacterial composition in Parkinson's disease. Movement Disorders: official Journal of the Movement Disorder Society 30 (10):1351–60. doi:10.1002/mds.263070.
  • Khoder, G., A. A. Al-Menhali, F. Al-Yassir, and S. M. Karam. 2016. Potential role of probiotics in the management of gastric ulcer. Experimental and Therapeutic Medicine 12 (1):3–17. doi: 10.3892/etm.2016.3293.
  • Kim, J. G., E. Lee, S. H. Kim, K. Y. Whang, S. Oh, and J. Y. Imm. 2009. Effects of a Lactobacillus casei 393 fermented milk product on bone metabolism in ovariectomised rats. International Dairy Journal 19 (11):690–5. doi: 10.1016/j.idairyj.2009.06.009.
  • Kim, Y. S., and S. B. Ho. 2010. Intestinal goblet cells and mucins in health and disease: Recent insights and progress. Current Gastroenterology Reports 12 (5):319–30. doi: 10.1007/s11894-010-0131-2.
  • Kline, K. A., and A. L. Lewis. 2016. Gram-positive uropathogens, polymicrobial urinary tract infection, and the emerging microbiota of the urinary tract. Microbiology Spectrum 4. doi: 10.1128/microbiolspec.UTI-0012-2012.
  • Koeth, R. A., B. S. Levison, M. K. Culley, J. A. Buffa, Z. Wang, J. C. Gregory, E. Org, Y. Wu, L. Li, J. D. Smith, et al. 2014. γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metabolism 20 (5):799–812. doi: 10.1016/j.cmet.2014.10.006.
  • Koues, O. I., P. L. Collins, M. Cella, M. L. Robinette, S. I. Porter, S. C. Pyfrom, J. E. Payton, M. Colonna, and E. M. Oltz. 2016. Distinct gene regulatory pathways for human innate versus adaptive lymphoid cells. Cell 165 (5):1134–46. doi: 10.1016/j.cell.2016.04.014.
  • Krajmalnik-Brown, R., C. Lozupone, D.-W. Kang, and J. B. Adams. 2015. Gut bacteria in children with autism spectrum disorders: Challenges and promise of studying how a complex community influences a complex disease. Microbial Ecology in Health and Disease 26:26914. doi: 10.3402/mehd.v26.26914.
  • Kurashima, Y., Y. Goto, and H. Kiyono. 2013. Mucosal innate immune cells regulate both gut homeostasis and intestinal inflammation. European Journal of Immunology 43 (12):3108–15. doi: 10.1002/eji.201343782.
  • Laschke, M. W., and M. D. Menger. 2016. The gut microbiota: A puppet master in the pathogenesis of endometriosis? Am. J. Obstet. Gynecol 215:e61. https://doi doi: 10.1016/j.ajog.2016.02.036.
  • Lambeth, S. M., T. Carson, J. Lowe, T. Ramaraj, J. W. Leff, L. Luo, C. J. Bell, and V. O. Shah. 2015. Composition, diversity and abundance of gut microbiome in prediabetes and type 2 diabetes. Journal of Diabetes and Obesity 2 (3):1–7. doi: 10.15436/2376-0949.15.031.
  • Landete, J. 2012. Updated knowledge about polyphenols: Functions, bioavailability, metabolism, and health. Critical Reviews in Food Science and Nutrition 52 (10):936–48. doi: 10.1080/10408398.2010.513779.
  • Larsen, N., F. K. Vogensen, F. W. Van Den Berg, D. S. Nielsen, A. S. Andreasen, B. K. Pedersen, W. A. Al-Soud, S. J. Sørensen, L. H. Hansen, and M. Jakobsen. 2010. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. Plos One 5 (2):e9085. doi: 10.1371/journal.pone.0009085.
  • Li, H., T. Li, D. E. Beasley, P. Heděnec, Z. Xiao, S. Zhang, J. Li, Q. Lin, and X. Li. 2016. Diet diversity is associated with beta but not alpha diversity of pika gut microbiota. Frontiers in Microbiology 7:1169. doi: 10.3389/fmicb.2016.01169.
  • Li, X. S., S. Obeid, R. Klingenberg, B. Gencer, F. Mach, L. Räber, S. Windecker, N. Rodondi, D. Nanchen, O. Muller, et al. 2017. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: A prognostic marker for incident cardiovascular events beyond traditional risk factors. European Heart Journal 38:814–24. doi: 10.1093/eurheartj/ehw582.
  • Ling, Z., F. Liu, L. Shao, Y. Cheng, and L. Li. 2017. Dysbiosis of the urinary microbiota associated with urine levels of proinflammatory chemokine interleukin-8 in female type 2 diabetic patients. Frontiers in Immunology 8:1032. doi: 10.3389/fimmu.2017.01032.
  • Lippert, K., L. Kedenko, L. Antonielli, I. Kedenko, C. Gemeier, M. Leitner, A. Kautzky-Willer, B. Paulweber, and E. Hackl. 2017. Gut microbiota dysbiosis associated with glucose metabolism disorders and the metabolic syndrome in older adults. Beneficial Microbes 8 (4):545–56. doi: 10.3920/BM2016.0184.
  • Liu, R. H. 2004. Potential synergy of phytochemicals in cancer prevention: Mechanism of action. The Journal of Nutrition 134 (12 Suppl):3479S–85. doi: 10.1093/jn/134.12.3479S.
  • Louis, P., and H. J. Flint. 2017. Formation of propionate and butyrate by the human colonic microbiota. Environmental Microbiology 19 (1):29–41. htpps://doi: 10.1111/1462-2920.13589.
  • Long, S. L., C. G. M. Gahan, and S. A. Joyce. 2017. Interactions between gut bacteria and bile in health and disease. Molecular Aspects of Medicine 56:54–65. doi: 10.1016/j.mam.2017.06.002.
  • Lyte, M. 2011. Probiotics function mechanistically as delivery vehicles for neuroactive compounds: Microbial endocrinology in the design and use of probiotics. BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology 33 (8):574–81. doi: 10.1002/bies.201100024.
  • Lyte, M. 2013. Microbial endocrinology in the microbiome-gut-brain axis: How bacterial production and utilization of neurochemicals influence behavior. PLoS Pathogens 9 (11):e1003726. doi: 10.1371/journal.ppat.1003726.
  • Macfabe, D. F. 2012. Short-chain fatty acid fermentation products of the gut microbiome: Implications in autism spectrum disorders. Microbial Ecology in Health and Disease 23. doi: 10.3402/mehd.v23i0.19260.
  • Macfarlane, G. T., and S. Macfarlane. 2012. Bacteria, colonic fermentation, and gastrointestinal health. Journal of AOAC International 95 (1):50–60. doi: 10.5740/jaoacint.sge_macfarlane.
  • Madan, J., D. Koestler, B. Stanton, L. Davidson, L. Moulton, M. Housman, J. Moore, M. F. Guill, H. Morrison, M. Sogin, et al. 2012. Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: Interaction between intestinal and respiratory tracts and impact of nutritional exposures. MBio 3 (4):e00251. doi: 10.1128/mBio.00251-12.
  • Manach, C., A. Scalbert, C. Morand, C. Rémésy, and L. Jiménez. 2004. Polyphenols: Food sources and bioavailability. The American Journal of Clinical Nutrition 79 (5):727–47. doi: 10.1093/ajcn/79.5.727.
  • Marchesi, J. R., D. H. Adams, F. Fava, G. D. Hermes, G. M. Hirschfield, G. Hold, M. N. Quraishi, J. Kinross, H. Smidt, K. M. Tuohy, et al. 2016. The gut microbiota and host health: A new clinical frontier. Gut 65 (2):330–9., doi: 10.1136/gutjnl-2015-309990.
  • Markowiak, P., and K. Śliżewska. 2017. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients 9:1021. doi: 10.3390/nu9091021.
  • Mazmanian, S. K., J. L. Round, and D. L. Kasper. 2008. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453 (7195):620–5. doi: 10.1038/nature07008.
  • McCabe, L., R. A. Britton, and N. Parameswaran. 2015. Prebiotic and probiotic regulation of bone health: Role of the intestine and its microbiome. Current Osteoporosis Reports 13 (6):363–71. doi: 10.1007/s11914-015-0292-x.
  • McColl, K. E. 2010. Clinical practice. Helicobacter pylori infection. The New England Journal of Medicine 362 (17):1597–604. doi: 10.1056/NEJMcp1001110.
  • Meng, S. J., and L. J. Yu. 2010. Oxidative stress, molecular inflammation and sarcopenia. International Journal of Molecular Sciences 11 (4):1509–26. doi: 10.3390/ijms11041509.
  • Miyoshi, J., and E. B. Chang. 2017. The gut microbiota and inflammatory bowel diseases. Translational Research: The Journal of Laboratory and Clinical Medicine 179:38–48. doi: 10.1016/j.trsl.2016.06.002.
  • Molyneaux, P. L., and T. M. Maher. 2013. The role of infection in the pathogenesis of idiopathic pulmonary fibrosis. European Respiratory Review: An Official Journal of the European Respiratory Society 22 (129):376–81. doi: 10.1183/09059180.00000713.
  • Molyneaux, P. L., and T. M. Maher. 2014. Respiratory microbiome in IPF: Cause, effect, or biomarker? The Lancet Respiratory Medicine 2 (7):511–3. doi: 10.1016/S2213-2600(14)70088-8.
  • Monira, S., S. Nakamura, K. Gotoh, K. Izutsu, H. Watanabe, N. H. Alam, H. P. Endtz, A. Cravioto, S. Ali, T. Nakaya, et al. 2011. Gut microbiota of healthy and malnourished children in Bangladesh. Frontiers in Microbiology 2:228. doi: 10.3389/fmicb.2011.00228.
  • Moraes, A. C. F., I. T. Silva, B. Almeida-Pititto, and S. R. G. Ferreira. 2014. [Intestinal microbiota and cardiometabolic risk: mechanisms and diet modulation]. Arquivos Brasileiros de Endocrinologia e Metabologia 58 (4):317–27. doi: 10.1590/0004-2730000002940.
  • Moreira, A. P. B., T. F. S. Texeira, A. B. Ferreira, M. C. G. Peluzio, and R. C. G. Alfenas. 2012. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. The British Journal of Nutrition 108 (5):801–9. doi: 10.1017/S0007114512001213.
  • Morris, A., J. M. Beck, P. D. Schloss, T. B. Campbell, K. Crothers, J. L. Curtis, S. C. Flores, A. P. Fontenot, E. Ghedin, L. Huang, et al. 2013. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. American Journal of Respiratory and Critical Care Medicine 187 (10):1067–75., doi: 10.1164/rccm.201210-1913OC.
  • Mortaz, E., I. M. Adcock, G. Folkerts, P. J. Barnes, A. Paul Vos, and J. Garssen. 2013. Probiotics in the management of lung diseases. Mediators of Inflammation 2013:1–10. doi: 10.1155/2013/751068.
  • Mueller, E. R., A. J. Wolfe, and L. Brubaker. 2017. Female urinary microbiota. Current Opinion in Urology 27 (3):282–6. doi: 10.1097/MOU.0000000000000396.
  • Narva, M., M. Collin, C. Lamberg-Allardt, M. Kärkkäinen, T. Poussa, H. Vapaatalo, and R. Korpela. 2004. Effects of long-term intervention with Lactobacillus helveticus-fermented milk on bone mineral density and bone mineral content in growing rats . Annals of Nutrition & Metabolism 48 (4):228–34. doi: 10.1159/000080455.
  • Neyrinck, A. M., V. F. Van Hée, N. Piront, F. De Backer, O. Toussaint, P. D. Cani, and N. M. Delzenne. 2012. Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice. Nutrition & Diabetes 2:e28. . PMid:23154683 doi: 10.1038/nutd.2011.24.
  • Nicholson, J. K., E. Holmes, J. Kinross, R. Burcelin, G. Gibson, W. Jia, and S. Pettersson. 2012. Host-gut microbiota metabolic interactions. Science (New York, N.Y.) 336 (6086):1262–7. doi: 10.1126/science.1223813.
  • O'brien, C. L., M. A. Bringer, K. E. Holt, D. M. Gordon, A. L. Dubois, N. Barnich, A. Darfeuille-Michaud, and P. Pavli. 2017. Comparative genomics of Crohn's disease-associated adherent-invasive Escherichia coli. Gut 66 (8):1382–9. doi: 10.1136/gutjnl-2015-311059.
  • O'Connor, E. M., E. A. O'Herlihy, and P. W. O'Toole. 2014. Gut microbiota in older subjects: Variation, health consequences and dietary intervention prospects. The Proceedings of the Nutrition Society 73 (4):441–51. doi: 10.1017/S0029665114000597.
  • Ohlsson, C., and K. Sjögren. 2015. Effects of the gut microbiota on bone mass. Trends in Endocrinology and Metabolism: TEM 26 (2):69–74. doi: 10.1016/j.tem.2014.11.004.
  • Olhagen, B., and I. Månsson. 1968. Intestinal Clostridium perfringens in rheumatoid arthritis and other collagen diseases 1. Acta Medica Scandinavica 184 (5):395–402. doi: 10.1111/j.0954-6820.1968.tb02478.x.
  • O'Mahony, S. M., V. D. Felice, K. Nally, H. M. Savignac, M. J. Claesson, P. Scully, J. Woznicki, N. P. Hyland, F. Shanahan, E. M. Quigley, et al., 2014. Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats. Neuroscience 277:885–901. doi: 10.1016/j.neuroscience.2014.07.054.
  • O'Mahony, S. M., G. Clarke, Y. E. Borre, T. G. Dinan, and J. F. Cryan. 2015. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behavioural Brain Research 277:32–48. doi: 10.1016/j.bbr.2014.07.027.
  • Palanisamy, N., and S. Manian. 2012. Protective effects of Asparagus racemosus on oxidative damage in isoniazid-induced hepatotoxic rats: An in vivo study. Toxicology and Industrial Health 28 (3):238–44. doi: 10.1177/0748233711410911.
  • Palm, N. W., M. R. de Zoete, and R. A. Flavell. 2015. Immune-microbiota interactions in health and disease. Clinical Immunology (Orlando, Fla.) 159 (2):122–7. doi: 10.1016/j.clim.2015.05.014.
  • Pamer, E. G. 2014. Fecal microbiota transplantation: Effectiveness, complexities, and lingering concerns. Mucosal Immunology 7 (2):210–4. doi: 10.1038/mi.2013.117.
  • Parnell, J. A., and R. A. Reimer. 2009. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. The American Journal of Clinical Nutrition 89 (6):1751–9. doi: 10.3945/ajcn.2009.27465.
  • Parsons, B. N., U. Z. Ijaz, R. D'Amore, M. D. Burkitt, R. Eccles, L. Lenzi, C. A. Duckworth, A. R. Moore, L. Tiszlavicz, A. Varro, et al. 2017. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use. PLoS Pathogens 13 (11):e1006653. doi:10.1371/journal.ppat.1006653.
  • Parvaneh, K., and R. Jamaluddin. 2014. Probiotics effectiveness on calcium absorption, bone mass density (BMD) and trabecular structure of bone. 3rd International Conference and Exhibition on Probiotics, Functional and Baby Foods 2014.
  • Paz, J. C., and M. P. West. 2013. Acute care handbook for physical therapists. Elsevier Health Sciences.
  • Pazzini, C. A., L. J. Pereira, T. A. Silva, C. C. Montalvany-Antonucci, S. Macari, L. S. Marques, and S. M. Paiva. 2017. Probiotic consumption decreases the number of osteoclasts during orthodontic movement in mice. Archives of Oral Biology 79:30–4. http://. doi: 10.1016/j.archoralbio.2017.02.017.
  • Pearce, M. M., M. J. Zilliox, A. B. Rosenfeld, K. J. Thomas-White, H. E. Richter, C. W. Nager, A. G. Visco, I. E. Nygaard, M. D. Barber, J. Schaffer, et al. 2015. The female urinary microbiome in urgency urinary incontinence. American Journal of Obstetrics and Gynecology 213:347.e341. doi: 10.1016/j.ajog.2015.07.009.
  • Petersen, C., and J. L. Round. 2014. Defining dysbiosis and its influence on host immunity and disease. Cellular microbiology 16 (7):1024–33. doi: 10.1111/cmi.12308.
  • Pichon, M., B. Lina, and L. Josset. 2017. Impact of the respiratory microbiome on host responses to respiratory viral infection. Vaccines 5 (4):40. http://. doi: 10.3390/vacinas5040040.
  • Pineda, M. L., S. F. Thompson, K. Summers, F. Leon, J. Pope, and G. Reid. 2011. A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Medical Science Monitor : international Medical Journal of Experimental and Clinical Research 17 (6):CR347–54. http://. doi: 10.12659/MSM.881808.
  • Pluznick, J. L., R. J. Protzko, H. Gevorgyan, Z. Peterlin, A. Sipos, J. Han, I. Brunet, L.-X. Wan, F. Rey, T. Wang, et al. 2013. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proceedings of the National Academy of Sciences of the United States of America 110 (11):4410–5., http://. doi: 10.1073/pnas.1215927110.
  • Pouillart, P. R., F. Dépeint, A. Abdelnour, L. Deremaux, O. Vincent, J.-C. Mazière, J.-Y. Madec, D. Chatelain, H. Younes, D. Wils, et al. 2010. Nutriose, a prebiotic low-digestible carbohydrate, stimulates gut mucosal immunity and prevents TNBS-induced colitis in piglets. Inflammatory Bowel Diseases 16 (5):783–94., doi: 10.1002/ibd.21130.
  • Puiman, P.,. B. Stoll, L. Molbak, A. C. de Bruijn, H. Schierbeek, M. Boye, G. Boehm, I. B. Renes, J. B. van Goudoever, and D. G. Burrin. 2013. Modulation of the gut microbiota with antibiotic treatment suppresses whole body urea production in neonatal pigs. American Journal of Physiology. Gastrointestinal and Liver Physiology 304 (3):G300–10. doi: 10.1152/ajpgi.00229.2011.
  • Quach, D., and R. A. Britton. 2017. Gut microbiota and bone health, understanding the gut-bone signaling axis, 47–58. Springer.
  • Qin, Y. X., H. Lam, S. Ferreri, and C. Rubin. 2010. Dynamic skeletal muscle stimulation and its potential in bone adaptation. Journal of Musculoskeletal & Neuronal Interactions 10 (1):12–24.
  • Qin, J., S. Li, J. Zhu, F. Zhang, S. Liang, W. Zhang, Y. Guan, D. Shen, Y. Peng, D. Zhang, et al. 2012. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490 (7418):55–60. http://. doi: 10.1038/nature11450.
  • Ramachandran, G. 2014. Gram-positive and gram-negative bacterial toxins in sepsis: A brief review. Virulence 5 (1):213–8. doi: 10.4161/viru.27024.
  • Raoult, D. 2017. Is there a link between urinary microbiota and bladder cancer? European Journal of Epidemiology 32 (3):255 doi: 10.1007/s10654-016-0213-z.
  • Reid, G., J. Jass, M. T. Sebulsky, and J. K. McCormick. 2003. Potential uses of probiotics in clinical practice. Clinical Microbiology Reviews 16 (4):658–672. http://. doi: 10.1128/CMR.16.4.658-672.2003.
  • Ridaura, V. K., J. J. Faith, F. E. Rey, J. Cheng, A. E. Duncan, A. L. Kau, N. W. Griffin, V. Lombard, B. Henrissat, J. R. Bain, et al. 2013. Cultured gut microbiota from twins discordant for obesity modulate adiposity and metabolic phenotypes in mice. Science 341 (6150):1241214–1241214., http://. doi: 10.1126/science.1241214.
  • Rodrigo, L., V. Beteta-Gorriti, N. Alvarez, C. Gómez de Castro, A. de Dios, L. Palacios, and J. Santos-Juanes. 2018. Cutaneous and mucosal manifestations associated with celiac disease. Nutrients 10 (7):800. htpps:// doi: 10.3390/nu10070800.
  • Rom, O., S. Kaisari, D. Aizenbud, and A. Z. Reznick. 2012. Lifestyle and sarcopenia-etiology, prevention, and treatment. Rambam Maimonides Medical Journal 3 (4):e0024. http://. doi: 10.5041/RMMJ.10091.
  • Romano, K. A., A. Martinez-del Campo, K. Kasahara, C. L. Chittim, E. I. Vivas, D. Amador-Noguez, E. P. Balskus, and F. E. Rey. 2017. Metabolic, epigenetic, and transgenerational effects of gut bacterial choline consumption. Cell Host Microbe 22 (3):279–290. e7. doi:10.1016/j.chom.2017.07.021.k.
  • Rosenthal, M., D. Goldberg, A. Aiello, E. Larson, and B. Foxman. 2011. Skin microbiota: Microbial community structure and its potential association with health and disease. Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 11 (5):839–848. doi: 10.1016/j.meegid.2011.03.022.
  • Roudsari, M. R., R. Karimi, S. Sohrabvandi, and A. Mortazavian. 2015. Health effects of probiotics on the skin. Critical Reviews in Food Science and Nutrition 55 (9):1219–1240. doi: 10.1080/10408398.2012.680078.
  • Round, J. L., and S. K. Mazmanian. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nature Reviews. Immunology 9 (5):313–323. doi: 10.1038/nri2515.
  • Ryan, K. K., V. Tremaroli, C. Clemmensen, P. Kovatcheva-Datchary, A. Myronovych, R. Karns, H. E. Wilson-Pérez, D. A. Sandoval, R. Kohli, F. Bäckhed, et al. 2014. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 509 (7499):183–188., http://. doi: 10.1038/nature13135.
  • Saad, N., C. Delattre, M. Urdaci, J. M. Schmitter, and P. Bressollier. 2013. Uma visão geral dos últimos avanços no campo probiótico e prebiótico. Lwt - Food Science and Technology 50 (1):1–16. http://. doi: 10.1007/s13197-012-0726-8.
  • Saeedi, B. J., D. J. Kao, D. A. Kitzenberg, E. Dobrinskikh, K. D. Schwisow, J. C. Masterson, A. A. Kendrick, C. J. Kelly, A. J. Bayless, D. J. Kominsky, et al. 2015. HIF-dependent regulation of claudin-1 is central to intestinal epithelial tight junction integrity. Molecular Biology of the Cell 26 (12):2252–2262., doi: 10.1091/mbc.E14-07-1194.
  • Sato, J., A. Kanazawa, T. Ikeda Yoshihara, H. Goto, H. Abe, K. Komiya, M. Kawaguchi, T. Shimizu, T. Ogihara, Y. Tamura, et al. 2014. Gut dysbiosis and detection of "live gut bacteria" in blood of Japanese patients with type 2 diabetes. Diabetes Care 37 (8):2343–50., http://. doi: 10.2337/dc13-2817.
  • Scheperjans, F., Aho, V. Pereira, P. A. Koskinen, K. Paulin, L. Pekkonen, E. Haapaniemi, E. Kaakkola, S. Eerola, ‐Rautio, J. Pohja, M, et al. 2015. Gut microbiota are related to Parkinson's disease and clinical phenotype. Movement Disorders: Official Journal of the Movement Disorder Society 30 (3):350–358., doi: 10.1002/mds.26069.
  • Schnabl, B., and D. A. Brenner. 2014. Interactions between the intestinal microbiome and liver diseases. Gastroenterology 146 (6):1513–1524. doi: 10.1053/j.gastro.2014.01.020.
  • Scholz-Ahrens, K. E., B. Adolphi, F. Rochat, D. V. Barclay, M. de Vrese, Y. Açil, and J. Schrezenmeir. 2016. Effects of probiotics, prebiotics, and synbiotics on mineral metabolism in ovariectomized rats—impact of bacterial mass, intestinal absorptive area and reduction of bone turn-over. NFS Journal 3:41–50. doi: 10.1016/j.nfs.2016.03.001.
  • Schuijt, T. J., J. M. Lankelma, B. P. Scicluna, e Melo, FdS. Roelofs, J. J. de Boer, J. D. Hoogendijk, A. J. de Beer, R. de Vos, A. Belzer, et al. 2016. The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 65 (4):575–583., doi: 10.1136/gutjnl-2015-309728.
  • Scott, K. P., S. W. Gratz, P. O. Sheridan, H. J. Flint, and S. H. Duncan. 2013. The influence of diet on the gut microbiota. Pharmacological Research 69 (1):52–60. doi: 10.1016/j.phrs.2012.10.020.
  • Sedighi, M., S. Razavi, F. Navab-Moghadam, M. E. Khamseh, F. Alaei-Shahmiri, A. Mehrtash, and N. Amirmozafari. 2017. Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals. Microbial Pathogenesis 111:362–369. doi: 10.1016/j.micpath.2017.08.038.
  • Sekirov, I., S. L. Russell, L. C. Antunes, and B. B. Finlay. 2010. Gut microbiota in health and disease. Physiological Reviews 90 (3):859–904. doi: 10.1152/physrev.00045.2009.
  • Senthong, V., Z. Wang, Y. Fan, Y. Wu, S. L. Hazen, and W. W. Tang. 2016. Trimethylamine N‐oxide and mortality risk in patients with peripheral artery disease. Journal of the American Heart Association 5:e004237. doi: 10.1161/JAHA.116.004237.
  • Severance, E. G., R. H. Yolken, and W. W. Eaton. 2016. Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: More than a gut feeling. Schizophrenia Research 176 (1):23–35. doi: 10.1016/j.schres.2014.06.027.
  • Sheh, A., and J. G. Fox. 2013. The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes 4 (6):505–531. doi: 10.4161/gmic.26205.
  • Shi, K., F. Wang, H. Jiang, H. Liu, M. Wei, Z. Wang, and L. Xie. 2014. Gut bacterial translocation may aggravate microinflammation in hemodialysis patients. Digestive Diseases and Sciences 59 (9):2109–2117. doi: 10.1007/s10620-014-3202-7.
  • Shih, D. M., Z. Wang, R. Lee, Y. Meng, N. Che, S. Charugundla, H. Qi, J. Wu, C. Pan, J. M. Brown, et al. 2015. Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis. Journal of Lipid Research 56 (1):22–37., doi: 10.1194/jlr.M051680.
  • Shreiner, A. B., J. Y. Kao, and V. B. Young. 2015. The gut microbiome in health and in disease. Current Opinion in Gastroenterology 31 (1):69–75. doi: 10.1097/MOG.0000000000000139.
  • Sin-Jin, M., and Y. Long-Jiang. 2010. Oxidative stress, molecular inflamammation and sarcopenia. International Journal of Molecular Sciences 11:1509–26. doi: 10.3390/ijms11041509.
  • Sirinathsinghji, E. 2018. The gut microbiome and cancer. Accessed February 28 2019. http://www.i-sis.org.uk/The_Gut_Microbiome_and_Cancer.php. ).
  • Sjögren, K., C. Engdahl, P. Henning, U. H. Lerner, V. Tremaroli, M. K. Lagerquist, F. Bäckhed, and C. Ohlsson. 2012. The gut microbiota regulates bone mass in mice. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research 27 (6):1357–1367. doi: 10.1002/jbmr.1588.
  • So, J. S., H. K. Kwon, C. G. Lee, H. J. Yi, J. A. Park, S. Y. Lim, K. C. Hwang, Y. H. Jeon, and S. H. Im. 2008. Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions. Molecular Immunology 45 (9):2690–9. doi: 10.1016/j.molimm.2007.12.010.
  • Sommer, F., and F. Bäckhed. 2013. The gut microbiota-masters of host development and physiology. Nature Reviews. Microbiology 11 (4):227–238. doi: 10.1038/nrmicro2974.
  • Stapleton, A. E. 2016. The vaginal microbiota and urinary tract infection. Microbiology Spectrum 4. doi: 10.1128/microbiolspec..
  • Strati, F., D. Cavalieri, D. Albanese, C. De Felice, C. Donati, J. Hayek, O. Jousson, S. Leoncini, D. Renzi, A. Calabrò, et al. 2017. New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome 5 (1):24. doi: 10.1186/s40168-017-0242-1.
  • Stümer, E. S., S. Casasola, M. C. Gall, and M. C. Gall. 2012. Importance of probiotics on the human intestinal mirobiota. Revista brasileira de nutrição clínica 27:264–272.
  • Sullivan, E. L., K. M. Riper, R. Lockard, and J. C. Valleau. 2015. Maternal high-fat diet programming of the neuroendocrine system and behavior. Hormones and Behavior 76:153–161. doi: 10.1016/j.yhbeh.2015.04.008.
  • Suzuki, T., N. Yoshinaga, and S. Tanabe. 2011. Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. The Journal of Biological Chemistry 286 (36):31263–31271. doi: 10.1074/jbc.M111.23814771.
  • Szeto, C. C., B. C. H. Kwan, K. M. Chow, K. B. Lai, K. Y. Chung, C. B. Leung, and P. K. T. Li. 2008. Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clinical Journal of the American Society of Nephrology 3 (2):431–436. http://. doi: 10.2215/CJN.03600807.
  • Szeto, C. C., B. C. H. Kwan, K. M. Chow, J. S. S. Kwok, K. B. Lai, P. M. S. Cheng, W. F. Pang, J. Kit-Chung Ng, M. H. M. Chan, L. C. W. Lit, et al. 2015. Circulating bacterial-derived DNA fragment level is a strong predictor of cardiovascular disease in peritoneal dialysis patients. Plos One 10 (5):e0125162. http://. doi: 10.1371/journal.pone.0125162.
  • Swann, J. R., E. J. Want, F. M. Geier, K. Spagou, I. D. Wilson, J. E. Sidaway, J. K. Nicholson, and E. Holmes. 2011. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proceedings of the National Academy of Sciences 108 (Supplement_1):4523–4530. http://. doi: 10.1073/pnas.1006734107.
  • Tang, W. W., Z. Wang, B. S. Levison, R. A. Koeth, E. B. Britt, X. Fu, Y. Wu, and S. L. Hazen. 2013. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. New England Journal of Medicine 368 (17):1575–1584. doi: 10.1056/NEJMoa1109400.
  • Tang, W. W., and S. L. Hazen. 2014. The contributory role of gut microbiota in cardiovascular disease. The Journal of Clinical Investigation 124 (10):4204–4211. doi: 10.1172/JCI72331.
  • Tang, W. W., T. Kitai, and S. L. Hazen. 2017. Gut microbiota in cardiovascular health and disease. Circulation Research 120 (7):1183–1196. doi: 10.1161/CIRCRESAHA.117.309715.
  • Thaiss, C. A., M. Levy, J. Suez, and E. Elinav. 2014. The interplay between the innate immune system and the microbiota. Current Opinion in Immunology 26:41–48. doi: 10.1016/j.coi.2013.10.016.
  • Thomas, C., A. Gioiello, L. Noriega, A. Strehle, J. Oury, G. Rizzo, A. Macchiarulo, H. Yamamoto, C. Mataki, M. Pruzanski, et al. 2009. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metabolism 10 (3):167–177. doi: 10.1016/j.cmet.2009.08.001.
  • Thomas-White, K. J., S. Kliethermes, L. Rickey, E. S. Lukacz, H. E. Richter, P. Moalli, P. Zimmern, P. Norton, J. W. Kusek, and A. J. Wolfe. 2017. Evaluation of the urinary microbiota of women with uncomplicated stress urinary incontinence. American Journal of Obstetrics and Gynecology 216:55. e51–55. doi: 10.1016/j.ajog.2016.07.049.
  • Ticinesi, A., F. Lauretani, C. Milani, A. Nouvenne, C. Tana, D. Del Rio, M. Maggio, M. Ventura, and T. Meschi. 2017. Aging gut microbiota at the cross-road between nutrition, physical frailty, and sarcopenia: Is there a gut–muscle axis. Nutrients 9 (12):1303. ? doi: 10.3390/nu9121303.
  • Tojo, R., A. Suarez, M. G. Clemente, C. G. de los Reyes-Gavilan, A. Margolles, M. Gueimonde, and P. Ruas-Madiedo. 2014. Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis. World Journal of Gastroenterology 20 (41):15163–15176. doi: 10.3748/wjg.v20.i41.15163.
  • Tomova, A., V. Husarova, S. Lakatosova, J. Bakos, B. Vlkova, K. Babinska, and D. Ostatnikova. 2015. Gastrointestinal microbiota in children with autism in Slovakia. Physiology & Behavior 138:179–187. doi: 10.1016/j.physbeh.2014.10.033.
  • Trombetti, A., K. Reid, M. Hars, F. Herrmann, E. Pasha, E. Phillips, and R. Fielding. 2016. Age-associated declines in muscle mass, strength, power, and physical performance: Impact on fear of falling and quality of life. Osteoporosis International 27 (2):463–471. doi: 10.1007/s00198-015-3236-5.
  • Troy, E. B., and D. L. Kasper. 2010. Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. Frontiers in Bioscience (Landmark Edition) 15:25–34. doi: 10.2741/3603.
  • Tsokos, G. C. 2011. Systemic lupus erythematosus. The New England Journal of Medicine 365 (22):2110–2121. doi: 10.1056/NEJMra1100359.
  • Tuohy, K. M., H. M. Probert, C. W. Smejkal, and G. R. Gibson. 2003. Using probiotics and prebiotics to improve gut health. Drug Discovery Today 8 (15):692–700. doi: 10.1016/S1359-6446(03)02746-6.
  • Turnbaugh, P. J., R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (7122):1027–1031. doi: 10.1038/nature05414.
  • Unger, M. M., J. Spiegel, K.-U. Dillmann, D. Grundmann, H. Philippeit, J. Bürmann, K. Faßbender, A. Schwiertz, and K.-H. Schäfer. 2016. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. Parkinsonism & Related Disorders 32:66–72. doi: 10.1016/j.parkreldis.2016.08.019.
  • Valdes, A. M., J. Walter, E. Segal, and T. D. Spector. 2018. Role of the gut microbiota in nutrition and health. BMJ (Clinical Research ed.) 361:k2179. doi: 10.1136/bmj.k2179..
  • Van Loo, J., P. Coussement, L. De Leenheer, H. Hoebregs, and G. Smits. 1995. On the presence of inulin and oligofructose as natural ingredients in the western diet. Critical Reviews in Food Science and Nutrition 35 (6):525–552. doi: 10.1080/10408399509527714.
  • Varian, B. J., S. Gourishetti, T. Poutahidis, J. R. Lakritz, T. Levkovich, C. Kwok, K. Teliousis, Y. M. Ibrahim, S. Mirabal, and S. E. Erdman. 2016. Beneficial bacteria inhibit cachexia. Oncotarget 7 (11):11803–11816. doi: 10.1097/MOG.0000000000000139.
  • Vieira, A. T., C. Fukumori, and C. M. Ferreira. 2016. New insights into therapeutic strategies for gut microbiota modulation in inflammatory diseases. Clinical & Translational Immunology 5 (6):e87. doi: 10.1038/cti.2016.38.
  • Vijayashankar, M., and N. Raghunath. 2012. Pustular psoriasis responding to probiotics–A new insight. Our Dermatology Online 3 (4):326–329. doi: 10.7241/ourd.20124.71.
  • Villa, C. R., W. E. Ward, and E. M. Comelli. 2017. Gut microbiota-bone axis. Critical Reviews in Food Science and Nutrition 57 (8):1664–1672. doi: 10.1080/10408398.2015.1010034.
  • Vital, M., A. Karch, and D. H. Pieper. 2017. Colonic Butyrate-producing communities in humans: As overview using omics data. mSystems 2 (6):e00130. htpps:// doi: 10.1128/mSystems.00130-17.
  • Vitetta, L., S. Coulson, A. Linnane, and H. Butt. 2013. The gastrointestinal microbiome and musculoskeletal diseases: A beneficial role for probiotics and prebiotics. Pathogens (Basel, Switzerland) 2 (4):606–626. doi: 10.3390/pathogens2040606.
  • Vrieze, A., P. F. de Groot, R. S. Kootte, M. Knaapen, E. van Nood, and M. Nieuwdorp. 2013. Fecal transplant: A safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease? Best Practice & Research. Clinical Gastroenterology 27 (1):127–137. doi: 10.1016/j.bpg.2013.03.00.
  • Xu, X., X. Jia, L. Mo, C. Liu, L. Zheng, Q. Yuan, and X. Zhou. 2017. Intestinal microbiota: A potential target for the treatment of postmenopausal osteoporosis. Bone Research 5:17046. doi: 10.1038/boneres.2017.46.
  • Walker, A. W., J. D. Sanderson, C. Churcher, G. C. Parkes, B. N. Hudspith, N. Rayment, J. Brostoff, J. Parkhill, G. Dougan, and L. Petrovska. 2011. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiology 11:7. doi: 10.1186/1471-2180-11-7.
  • Wang, Z., E. Klipfell, B. J. Bennett, R. Koeth, B. S. Levison, B. DuGar, A. E. Feldstein, E. B. Britt, X. Fu, Y. M. Chung, et al. 2011. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472 (7341):57–63., doi: 10.1038/nature09922.
  • Wang, J., Y. Wang, W. Gao, B. Wang, H. Zhao, Y. Zeng, Y. Ji, and D. Hao. 2017. Diversity analysis of gut microbiota in osteoporosis and osteopenia patients. PeerJ 5:e3450. doi: 10.7717/peerj.3450.
  • Wasilewska, J., and M. Klukowski. 2015. Gastrointestinal symptoms and autism spectrum disorder: Links and risks–a possible new overlap syndrome. Pediatric Health, Medicine and Therapeutics 6:153–166. doi: 10.2147/PHMT.S85717.
  • Weiss, G. A., and T. Hennet. 2017. Mechanisms and consequences of intestinal dysbiosis. Cellular and Molecular Life Sciences: CMLS 74 (16):2959–2977. doi: 10.1007/s00018-017-2509-x.
  • Whisner, C. M., and C. M. Weaver. 2017. Prebiotics and bone, understanding the gut-bone Signaling Axis, 201–24. Springer.
  • Whiteside, S. A., H. Razvi, S. Dave, G. Reid, and J. P. Burton. 2015. The microbiome of the urinary tract—A role beyond infection. Nature Reviews. Urology 12 (2):81, 81–90. doi: 10.1038/nrurol.2014.361.
  • Williams, B. L., M. Hornig, T. Parekh, and W. I. Lipkin. 2012. Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. MBio 3 (1):e00261. doi: 10.1128/mBio.00261-11.
  • Yan, J., J. W. Herzog, K. Tsang, C. A. Brennan, M. A. Bower, W. S. Garrett, B. R. Sartor, A. O. Aliprantis, and J. F. Charles. 2016. Gut microbiota induce IGF-1 and promote bone formation and growth. Proceedings of the National Academy of Sciences of the United States of America 113 (47):E7554–E7563. doi: 10.1073/pnas.1607235113.
  • Yang, T., M. M. Santisteban, V. Rodriguez, E. Li, N. Ahmari, J. M. Carvajal, M. Zadeh, M. Gong, Y. Qi, J. Zubcevic, et al. 2015. Gut dysbiosis is linked to hypertension. Hypertension (Dallas, Tex. : 1979) 65 (6):1331–1340., doi: 10.1161/HYPERTENSIONAHA.115.05315.
  • Yang, Y. J., and B. S. Sheu. 2016. Metabolic interaction of Helicobacter pylori infection and gut microbiota. Microorganisms 4 (1):15. doi: 10.3390/microorganisms4010015.
  • Yang, X. 2018. Relationship between Helicobacter pylori and Rosacea: Review and discussion. BMC Infectious Diseases 18 (1):318. doi: 10.1186/s12879-018-3232-4..
  • Yano, J. M., K. Yu, G. P. Donaldson, G. G. Shastri, P. Ann, L. Ma, C. R. Nagler, R. F. Ismagilov, S. K. Mazmanian, and E. Y. Hsiao. 2015. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161 (2):264–276. doi: 10.1016/j.cell.2015.02.047.
  • Yoo, D. G., M. Winn, L. Pang, S. M. Moskowitz, H. L. Malech, T. L. Leto, and B. Rada. 2014. Release of cystic fibrosis airway inflammatory markers from Pseudomonas aeruginosa–stimulated human neutrophils involves NADPH oxidase-dependent extracellular DNA trap formation. Journal of Immunology (Baltimore, Md. : 1950) 192 (10):4728–4738. doi: 10.4049/jimmunol.1301589.
  • Zeeuwen, P. L., M. Kleerebezem, H. M. Timmerman, and J. Schalkwijk. 2013. Microbiome and skin diseases. Current Opinion in Allergy and Clinical Immunology 13 (5):514–520. doi: 10.1097/ACI.0b013e328364ebeb.
  • Zhang, Y. Z., and Y. Y. Li. 2014. Inflammatory bowel disease: Pathogenesis. World Journal of Gastroenterology 20 (1):91–99. doi: 10.3748/wjg.v20.i1.91.
  • Zhang, W., Y. H. Zhu, D. Zhou, Q. Wu, D. Song, J. Dicksved, and J. F. Wang. 2017. Oral administration of a select mixture of Bacillus probiotics affects the gut microbiota and goblet cell function following Escherichia coli challenge in newly weaned pigs of genotype MUC4 that are supposed to be enterotoxigenic E. coli F4ab/ac receptor negative. Applied and Environmental Microbiology 83 (3):e02747. doi: 10.1128/AEM.02747-16.
  • Zhu, W., J. C. Gregory, E. Org, J. A. Buffa, N. Gupta, Z. Wang, L. Li, X. Fu, Y. Wu, M. Mehrabian, et al. 2016. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165 (1):111–124. doi: 10.1016/j.cell.2016.02.011.
  • Zhu, X., Y. Han, J. Du, R. Liu, K. Jin, and W. Yi. 2017. Microbiota-gut-brain axis and the central nervous system. Oncotarget 8 (32):53829–53838. doi: 10.18632/oncotarget.17754.
  • Zhuang, Z. Q., L. L. Shen, W. W. Li, X. Fu, F. Zeng, L. Gui, Y. Lü, M. Cai, C. Zhu, Y. L. Tan, et al. 2018. Gut microbiome is altered in patients with Alzheimer’s disease. Journal of Alzheimer's Disease. 63:1–10. doi: 10.3233/JAD-180176.
  • Zitvogel, L., L. Galluzzi, S. Viaud, M. Vétizou, R. Daillère, M. Merad, and G. Kroemer. 2015. Cancer and the gut microbiota: An unexpected link. Science Translational Medicine. doi: 10.1126/scitranslmed.3010473.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.